RE:RE:Another Stevie bounce!!I listened to his commentary on BNN.
1. He's been adding to his position
2. He stated that valuation for THINK, and also healthtech more generally, is very compelling at current levels. Think is arguably the cheapest stock in the sector despite having one of the strongest organic growth rates. The organic part is critical and given comments I've heard from industry experts it would seem that consensus is around a long term 20%+ exponential growth rate with 15% being more likely in earlier years.
3. A very intersting point: Stephen cited that the Principals at North West Health Care have been accumulating shares of Think as of late. That's an interesting data point because it shows that people in the health industry really believe in the company and its prospects. As an aside, I would add that medical professionals tend to be very conservative investors so having conviction in a name like Think speaks volumes IMO.